An independent, non-neuronal cholinergic system in lymphocytes and its roles in regulation of immune function

Folia Pharmacologica Japonica

Volumn 123, Issue 3, 2004, Pages 179-188

  Fujii, Takeshi ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

Acetylcholine; Lymphocytes; Muscarinic receptor; Nicotinic receptor; Non neuronal cholinergic system

Indexed keywords

ACETYLCHOLINE; ACETYLCHOLINESTERASE; ADENYLATE CYCLASE; CALCIUM ION; CARBACHOL; CD3 ANTIGEN; CHOLINE ACETYLTRANSFERASE; CYCLIC AMP; CYCLIC GMP; DNA; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA; MUSCARINIC RECEPTOR; NEUROTRANSMITTER; NICOTINE; NICOTINIC RECEPTOR; NITRIC OXIDE; OXOTREMORINE; PHOSPHOLIPASE C; PHYTOHEMAGGLUTININ; PILOCARPINE; PROSTAGLANDIN E2; PROTEIN KINASE C; T LYMPHOCYTE RECEPTOR; THYMOCYTE ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL MODEL; ANTIGEN PRESENTING CELL; CALCIUM CELL LEVEL; CHOLINERGIC SYSTEM; CONFERENCE PAPER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNE SYSTEM; LYMPHOCYTE; NONHUMAN; RAT; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

ACETYLCHOLINE; ANIMALS; HUMANS; LYMPHOCYTES; RECEPTORS, CHOLINERGIC;

EID: 1842475336     PISSN: 00155691     EISSN: None     Source Type: Journal    
DOI: 10.1254/fpj.123.179     Document Type: Conference Paper

References (50)

1. Wessler I, Kirkpatrick CJ, Racké K. Non-neuronal acetylcholine, a locally acting molecule widely distributed in biological system: expression and function in humans. Pharmacol Ther. 1998;77:59-79.
2. Grando SA, Kawashima K, Wessler I. Editorial: the non-neuronal cholinergic system in humans. Life Sci. 2003;72:2009-2012.
3. Horiuchi Y, Kimura R, Kato N, et al. Evolutional study on acetylcholine expression. Life Sci. 2003;72:1745-1756.
4. Kawashima K, Ishikawa H, Mochizuki M. Radioimmuoassay for acetylcholine in the rat brain. J Pharmacol Methods. 1980;3:115-123.
5. Kawashima K, Fujii T. Extraneuronal cholinergic system in lymphocytes. Pharmacol Ther. 2000;86:29-48.
6. Sakuragawa N, Elwan MA, Uchida S, Fujii T, Kawashima K. The non-neuronal cholinergic system: non-neuronal neurotransmitters and neurotrophic factors in amniotic epithelial cell: expression and function in humans and monkey. Jpn J Pharmacol. 2001;85:20-23.
7. Horikoshi T, Fujii T, Kawashima K, Sakuragawa N. Acetylcholine increase in amniotic fluid of experimental rats for intrauterine growth retardation. Life Sci. 2003;72:2145-2150.
8. Kawashima K, Fujii T. The lymphocytic cholinergic system and its contribution to the regulation immune activity. Life Sci. 2003;74:675-696.
9. Maslinski W. Cholinergic receptors of lymphocytes. Brain Behav Immun. 1989;3:1-14.
10. Rinner I, Schauenstein K. The parasympathetic nervous system takes part in the immunoneuroendocrine dialogue. J Neuroimmunol. 1991;34:165-172.
11. Fujii T, Kawashima K. The non-neuronal cholinergic system: an independent non-neuronal cholinergic system in lymphocytes. Jpn J Pharmacol. 2001;85:11-15.
12. Kawashima K, Fujii T. The lymphocytic cholinergic system and its biological function. Life Sci. 2003;72:2101-2110.
13. Oosawa H, Fujii T, Kawashima K. Nerve growth factor increases the synthesis and release of acetylcholine and the expression of vesicular acetylcholine transporter in primary cultured rat embryonic septal cells. J Neurosci Res. 1999;57:381-387.
14. Fujii T, Yamada S, Yamaguchi N, Fujimoto K, Suzuki T, Kawashima K. Species differences in the concentration of acetylcholine, a neurotransmitter, in whole blood and plasma. Neurosci Lett. 1995;201:207-210.
15. Yamada S, Fujii T, Kawashima K. Oral administration of KW-5092, a novel gastroprokinetic agent with acetylcholinesterase inhibitory and acetylcholine release enhancing activities, cause a dose-dependent increase in the blood acetylcholine content of beagle dogs. Neurosci Lett. 1997;225:25-28.
16. Kawashima K, Oohata H, Fujimoto K, Suzuki T. Extraneuronal localization of acetylcholine and its release upon nicotinic stimulation in rabbits. Neurosci Lett. 1989;104:336-339.
17. Kawashima K, Kajiyama K, Suzuki T, Fujimoto K. Presence of acetylcholine in blood and its localization in circulating mononuclear leukocytes of humans. Biog Amines. 1993;9:251-258.
18. Fujii T, Mori H, Tominaga T, Hayasaka I, Kawashima K. Maintenance of constant blood acetylcholine content before and after feeding in young chimpanzees. Neurosci Lett. 1997;227:21-24.
19. Fujimoto K, Matsui M, Fujii T, Kawashima K. Decreased acetylcholine content and choline acetyltransferase mRNA expression in circulating mononuclear leukocytes and lymphoid organs of spontaneously hypertensive rat. Life Sci. 2001;69:1629-1638.
20. Tuček S. Choline acetyltransferase and the synthesis of acetylcholine. In: Whittaker VP, editor. Handbook of Experimental Pharmacology, Vol. 86 The Cholinergic Synapse. Berlin: Springer Verlag; 1988. p. 125-165.
21. Fujii T, Tsuchiya T, Yamada S, et al. Localization and synthesis of acetylcholine in human leukemic T cell lines. J Neurosci Res. 1996;44:66-72.
22. Rinner I, Kawashima K, Schauenstein K. Rat lymphocytes produce and secrete acetylcholine in dependence of differentiation and activation. J Neuroimmunol. 1998;81:31-37.
23. Fujii T, Yamada S, Misawa H, et al. Expression of choline acetyltransferase mRNA and protein in T-lymphocytes. Proc Jpn Acad. 1995;71B:231-235.
24. Fujii T, Tajima S, Yamada S, et al. Constitutive expression of mRNA for the same choline acetyltransferase as that in the nervous system, an acetylcholine-synthesizing enzyme, in human leukemic T-cell lines. Neurosci Lett. 1999;259:71-74.
25. Fujii T, Yamada S, Watanabe Y, et al. Induction of choline acetyltransferase mRNA in human mononuclear leukocytes stimulated by phytohemagglutinin, a T-cell activator. J Neuroimmunol. 1998;82:101-107.
26. Fujii T, Watanabe Y, Fujimoto K, Kawashima K. Expression of acetylcholine in lymphocytes and modulation of an independent lymphocytic cholinergic activity by immunological stimulation. Biog Amines. 2003;17:373-386.
27. Ogawa H, Fujii T, Watanabe Y, Kawashima K. Expression of multiple mRNA species for choline acetyltransferase in human T-lymphocytes. Life Sci. 2003;72:2127-2130.
28. Tayebati SK, El-Assouad D, Ricci A, Amenta F. Immunological and immunocytochemical characterization of cholinergic markers in human peripheral blood lymphocytes. J Neuroimmunol. 2002;132:147-155.
29. Sato KZ, Fujii T, Watanabe Y, et al. Diversity of mRNA expression for muscarinic acetylcholine receptor subtypes and neuronal nicotinic acetylcholine receptor subunits in human mononuclear leukocytes and leukemic cell lines. Neurosci Lett. 1999;266:17-20.
30. Costa P, Auger CB, Traver DJ, Costa LG. Identification of m3, m4 and m5 subtypes of muscarinic receptor mRNA in human blood mononuclear cells. J Neuroimmunol. 1995;60:45-51.
31. Hellström-Lindahl E, Nordberg A. Muscarinic receptor subtypes in subpopulations of human blood mononuclear cells as analyzed by RT-PCR technique. J Neuroimmunol. 1996;68:139-144.
32. 2+ in Jurkat, a human leukemic helper T lymphocyte line. Mol Pharmacol. 1993;43:356-364.
33. Fujino H, Kitamura Y, Yada T, Uehara T, Nomura Y. Stimulatory roles of muscarinic acetylcholine receptors in T cell antigen receptor/CD3 complex-mediated interleukin-2 production in human peripheral blood lymphocytes. Mol Pharmacol. 1997;51:1007-1014.
34. Milhovilovic M, Roses AD. Expression of α-3, α-5, and β-4 neuronal acetylcholine receptor subunit transcripts in normal and myasthenia gravis thymus. J Immunol. 1993;151:6517-6524.
35. Hiemke C, Stolp M, Reuss S, et al. Expression of alpha subunit genes of nicotinic acetylcholine receptors in human lymphocytes. Neurosci Lett. 1996;214:171-174.
36. Toyabe S, Iiai T, Fukuda M, et al. Identification of nicotinic acetylcholine receptors in lymphocytes in the periphery as well as thymus in mice. Immunology. 1997;92:201-205.
37. Kuo Y-P, Lucero L, Michaels J, DeLuca D, Lukas RJ. Differential expression of nicotinic acetylcholine receptor subunits in fetal and neonatal mouse thymus. J Neuroimmunol. 2002;130:140-154.
38. Okuda T, Haga T, Kanai Y, Endou H, Ishihara T, Katsura I. Identification and characterization of the high-affinity choline transporter. Nature Neurosci. 2000;3:120-125.
39. Okuda T, Haga T. Functional characterization of the human high-affinity choline transporter. FEBS Lett. 2000;484:92-97.
40. Fujii T, Okuda T, Haga T, Kawashima K. Detection of the high-affinity choline transporter in the MOLT-3 human leukemic T-cell line. Life Sci. 2003;72:2131-2134.
41. 5 muscarinic acetylcholine receptor in human T- and B-lymphocytes during immunological responses. Neurochem Res. 2003;28:423-429.
42. Fujii T, Ushiyama N, Hosonuma K, Suenaga A, Kawashima K. Effects of human antithymocyte globulin on acetylcholine synthesis, its release and choline acetyltransferase transcription in a human leukemic T-cell line. J Neuroimmunol. 2002;128:1-8.
43. Suenaga A, Fujii T, Ogawa H, et al. Up-regulation of lymphocytic cholinergic actitivity by ONO-4819, a selective prostaglandin E4 receptor agonist, in MOLT-3 human leukemic T cells. Vasc Pharmacol. In press.
44. Horiuchi Y, Fujii T, Kamimura Y, Kawashima K. The endogenous, immunologically active peptide apelin inhibits lymphocytic cholinergic activity. J Neuroimmunol. 2003;144:46-52.
45. 2+ oscillation and c-fos gene expression induced via muscarinic acetylcholine receptor in human T- and B-cell lines. Naunyn Schmiedebergs Arch Pharmacol. 2000;362:14-21.
46. 3 muscarinic acetylcholine receptors in human T- and B-cells. Jpn J Pharmacol. 2000;84:124-132.
47. Kamimura Y, Fujii T, Kojima H, Nagano T, Kawashima K. Nitric oxide (NO) synthase mRNA expression and NO production via muscarinic acetylcholine receptor-mediated pathways in the CEM, human leukemic T-cell line. Life Sci. 2003;72:2151-2154.
48. 2+ signaling and down-regulation of nicotinic acetylcholine receptor subunit expression in the CEM human leukemic T-cell line. Life Sci. 2003;72:2155-2158.
49. Borovikova LV, Ivanova S, Zhang M, et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature. 2000;405:458-462.
50. Takeichi N. Age-related immunological disorders in an animal model for hypertension, SHR rats. In: Saito H, Yamori Y, Minami M, Parvez SH, editors. Progress in Hypertension, Vol. 3 New Advances in SHR Research: Pathology & Pharmacology. Utrecht: VSP; 1995. p. 33-43.